Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference

GAITHERSBURG, Md., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that Stanley C. Erck, President and CEO, will present at the 27^th Annual Piper Jaffray Healthcare Conference.

Conference details are as follows:

Date: Tuesday, December 1, 2015
Time: 2:00 p.m. U.S. Eastern Time
Location: New York Palace Hotel, New York City
Live webcast: http://edge.media-server.com/m/p/ui3ne8dn

The webcast and a replay of the presentation will also be accessible under the "Investors/Events" section of the Novavax website at novavax.com.

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.

Contact:

Novavax, Inc.

Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations

[e-mail]
240-268-2000

Russo Partners, LLC

David Schull
Todd Davenport, Ph.D.

[e-mail]
[e-mail]
212-845-4271

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via Globenewswire

HUG#1969132